Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Egypt / NCT06983353
Starting soon Not applicable

Guided Growth Technique Use In Treatment Of Hip Sublaxation In CP Childern

NCT06983353 · tracked via the Priya Life Science Egypt tracker
Sponsor
Mohamed Adel Fathy Abdel aleem
Phase
Not applicable
Started
2025-10-01
Last updated
2025-09-16

Condition(s) studied

Cerebral Palsy (CP)Guided Growth

Investigational drug(s) / intervention(s)

transphyseal screw

transphyseal screw: transphyseal screw in proximal femoral physis

Study summary

To evaluate the change in femoral neck-shaft angle (coxa valga) following transphyseal screw insertion in children with CP.

Eligibility

Sex
ALL
Min age
3 Years
Max age
12 Years
Healthy volunteers
No
Inclusion Criteria: * children aged 3-12 yrs diagnosed with CP ( GMFCS level l\_lV ) * Neck-Shaft angle \>150 * early hip sub laxation ( migration percentage \< 50% ) Exclusion Criteria: * Sever hip sub laxation ( migration percentage\> 50 % ) * Children below 3 yrs and above 12 * Pathological bone * medical contraindications to surgery

Primary outcome measure(s)

  • Change in femoral neck-shaft angle (measured on anteroposterior pelvic radiographs). — - Regular follow-up at 1.5, 3, 6, 12, and 24 months .

Trial sites (1)

FacilityCityRegionStatus
Assiut university hospital Asyut Egypt

Other trials for the same condition

Effect of Reactive Functional Motor Challenge Training on Dynamic Balance and Functional Mobility in Children With Spastic Diplegic Cerebral Palsy: A Randomized Comparative Trial. Active, not recruiting
Effect of Task Specific Electrical Stimulation on Upper Limb Gross Motor Skills in Children With Spastic Quadriplegia Recruiting
Aquatic Based Exercises Versus Mirror Therapy on Hand Dexterity and Strength in Hemiplegic Child Active, not recruiting
Effect of Transcranial Direct Current Stimulation on Risk of Falling in Cerebral Palsy Spastic Hemiplegic Children Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06983353 on ClinicalTrials.gov ↗ ← All trials in Egypt